Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 24 Prostatic Neoplasms 16 Sarcoma 9 Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 5 Uterine Cervical Neoplasms 4 Endometrial Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Liposarcoma, Myxoid 3 Head and Neck Neoplasms 3 Glioblastoma 3 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma, Synovial 2 Radiation Injuries 2 Pancreatic Neoplasms 2 Neurofibrosarcoma 2 Neoplasms 2 Melanoma 2 Lymphatic Metastasis 2 Liposarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Fibrosarcoma 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2 Advanced Refractory Solid Tumors 2 Uterine Neoplasms 1 Urothelial Cancer 1 Urogenital Neoplasms 1

Interventions

Cyclophosphamide 16 Temozolomide 13 Vincristine 10 Irinotecan 8 Melphalan 7 Doxorubicin 7 Topotecan 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 fludarabine 5 cabozantinib 5 Etoposide 5 Drug Therapy 5 liposomal doxorubicin 4 Sirolimus 4 Ifosfamide 4 Filgrastim 4 regorafenib 3 pegfilgrastim 3 irinotecan sucrosofate 3 fludarabine phosphate 3 Zoledronic Acid 3 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Gemcitabine 3 Cisplatin 3 Bone Marrow Transplantation 3 Albumin-Bound Paclitaxel 3 pegylated granulocyte colony-stimulating factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma, Ewing × Radiation Dose Hypofractionation × Clear all

NCT07188532 2026-06-04

BEAR

Mayo Clinic

Phase NA Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡